Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider that develops and commercializes treatment software and devices for brachytherapy. Its proprietary treatment planning system supports radioactive particle implantation, a radiotherapy that places radioactive sources inside the patient to kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for various malignant tumors that can determine target volume, prescription dose, and dose limits to protect organs at risk, and produce dose distribution plans for brachytherapy in cancer patients. Founded in 1998 and headquartered in Beijing, China, Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD.

PTHL▼

Class Action Lawsuit Filed Against iTonic Holdings for Alleged Market Manipulation Scheme

A shareholder class action lawsuit has been filed against iTonic Holdings Ltd., formerly known as Pheton Holdings Ltd., alleging that the company made false or misleading statements and failed to disclose a market manipulation and fraudulent promotion scheme involving social-media misinformation and impersonators. The lawsuit claims that iTonic's public statements omitted any mention of fraudulent trading or the risk of market manipulation used to drive its stock price, leaving securities at unique risk of extreme volatility and trading halts. Investors who purchased iTonic shares between September 5, 2024 and July 29, 2025 and suffered losses are encouraged to contact Holzer & Holzer, LLC to discuss their legal rights. The deadline to seek appointment as lead plaintiff is September 29, 2026.

ITOC ▼PTHL ▼

GlobeNewswire·44dRead more →